Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$8.72 - $11.56 $2,249 - $2,982
258 Added 2.4%
11,025 $122,000
Q3 2022

Oct 27, 2022

SELL
$8.48 - $11.13 $12,482 - $16,383
-1,472 Reduced 12.03%
10,767 $92,000
Q2 2022

Aug 01, 2022

SELL
$9.95 - $12.27 $13,492 - $16,638
-1,356 Reduced 9.97%
12,239 $128,000
Q1 2022

Apr 20, 2022

SELL
$9.81 - $15.4 $1,236 - $1,940
-126 Reduced 0.92%
13,595 $148,000
Q4 2021

Feb 03, 2022

SELL
$12.09 - $14.68 $16,913 - $20,537
-1,399 Reduced 9.25%
13,721 $186,000
Q3 2021

Oct 14, 2021

SELL
$13.25 - $15.13 $87,529 - $99,948
-6,606 Reduced 30.41%
15,120 $205,000
Q2 2021

Jul 09, 2021

BUY
$12.97 - $16.15 $118,027 - $146,965
9,100 Added 72.07%
21,726 $310,000
Q1 2021

Apr 21, 2021

BUY
$13.59 - $18.54 $171,587 - $234,086
12,626 New
12,626 $176,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Investors Asset Management Of Georgia Inc Portfolio

Follow Investors Asset Management Of Georgia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.